Efficacy, Safety and Tolerability of Lacosamide in Patients With Gain-of-function Nav1.7 Mutations Related Small Fiber Neuropathy: a Randomized, Double-blind, Placebo Controlled, Crossover Trial

Trial Profile

Efficacy, Safety and Tolerability of Lacosamide in Patients With Gain-of-function Nav1.7 Mutations Related Small Fiber Neuropathy: a Randomized, Double-blind, Placebo Controlled, Crossover Trial

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 21 Sep 2017

At a glance

  • Drugs Lacosamide (Primary)
  • Indications Peripheral neuropathies
  • Focus Therapeutic Use
  • Acronyms MaYa-Nav1.7
  • Most Recent Events

    • 21 Sep 2017 According to European clinical trials database the trial has been completed
    • 26 Aug 2016 Planned End Date changed from 1 Oct 2016 to 1 Mar 2017.
    • 26 Aug 2016 Planned primary completion date changed from 1 Jul 2016 to 1 Feb 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top